Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Forgone care and financial burden due to out-of-pocket payments within the German health care system.

Bremer P.

Health Econ Rev. 2014 Dec;4(1):36. doi: 10.1186/s13561-014-0036-0. Epub 2014 Dec 20.

2.

The possibilities of day surgery system development within the health policy in Slovakia.

Šoltés V, Gavurová B.

Health Econ Rev. 2014 Dec;4(1):35. doi: 10.1186/s13561-014-0035-1. Epub 2014 Dec 28.

3.

Willingness to pay for informal care in France: the value of funding support interventions for caregivers.

Gervès-Pinquié C, Bellanger MM, Ankri J.

Health Econ Rev. 2014 Dec;4(1):34. doi: 10.1186/s13561-014-0034-2. Epub 2014 Dec 13.

4.

A multilevel analysis of prenatal care and birth weight in Kenya.

Awiti JO.

Health Econ Rev. 2014 Dec;4(1):33. doi: 10.1186/s13561-014-0033-3. Epub 2014 Nov 23.

5.

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany.

Neubauer S, Cifaldi M, Mittendorf T, Ganguli A, Wolff M, Zeidler J.

Health Econ Rev. 2014 Dec;4(1):32. doi: 10.1186/s13561-014-0032-4. Epub 2014 Nov 23.

6.

Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland.

Lebioda A, Gasche D, Dippel FW, Theobald K, Plantör S.

Health Econ Rev. 2014 Dec;4(1):31. doi: 10.1186/s13561-014-0031-5. Epub 2014 Nov 30.

7.

Commercial plasma donation and individual health in impoverished rural China.

Chen X.

Health Econ Rev. 2014 Dec;4(1):30. doi: 10.1186/s13561-014-0030-6. Epub 2014 Nov 18.

9.

Defining hospital markets - an application to the German hospital sector.

Hentschker C, Mennicken R, Schmid A.

Health Econ Rev. 2014 Dec;4(1):28. doi: 10.1186/s13561-014-0028-0. Epub 2014 Nov 26.

10.
11.

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

Tetteh EK, Morris S.

Health Econ Rev. 2014 Dec;4(1):26. doi: 10.1186/s13561-014-0026-2. Epub 2014 Oct 23.

12.

Costing of diabetes mellitus type II in Cambodia.

Flessa S, Zembok A.

Health Econ Rev. 2014 Dec;4(1):24. doi: 10.1186/s13561-014-0024-4. Epub 2014 Nov 1.

13.

Pharmaceutical regulation in Europe and its impact on corporate R&D.

Eger S, Mahlich JC.

Health Econ Rev. 2014 Dec;4(1):23. doi: 10.1186/s13561-014-0023-5. Epub 2014 Oct 3.

14.

Parents' willingness to pay for the prevention of childhood overweight and obesity.

Kesztyüs D, Lauer R, Schreiber AC, Kesztyüs T, Kilian R, Steinacker JM.

Health Econ Rev. 2014 Dec;4(1):20. doi: 10.1186/s13561-014-0020-8. Epub 2014 Sep 16.

15.

Effect of health insurance coverage on labor allocation: evidence from US farm households.

D'Antoni JM, Mishra AK, Khanal AR.

Health Econ Rev. 2014 Dec;4(1):19. doi: 10.1186/s13561-014-0019-1. Epub 2014 Oct 29.

16.

Modeling rheumatoid arthritis using different techniques - a review of model construction and results.

Scholz S, Mittendorf T.

Health Econ Rev. 2014 Dec;4(1):18. doi: 10.1186/s13561-014-0018-2. Epub 2014 Sep 16.

17.

Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand.

Yamwong S, Permsuwan U, Tinmanee S, Sritara P.

Health Econ Rev. 2014 Dec;4(1):17. doi: 10.1186/s13561-014-0017-3. Epub 2014 Nov 14.

18.

Reservation wage of female volunteer community health workers in Dhaka urban slums: a bidding game approach.

Alam K, Tasneem S, Huq M.

Health Econ Rev. 2014 Dec;4(1):16. doi: 10.1186/s13561-014-0016-4. Epub 2014 Sep 5.

19.

Economic impact of HIV/AIDS: a systematic review in five European countries.

Trapero-Bertran M, Oliva-Moreno J.

Health Econ Rev. 2014 Dec;4(1):15. doi: 10.1186/s13561-014-0015-5. Epub 2014 Sep 16.

20.

Macro-level factors impacting geographic disparities in cancer screening.

Mobley LR, Kuo TM, Traczynski J, Udalova V, Frech HE 3rd.

Health Econ Rev. 2014 Dec;4(1):13. doi: 10.1186/s13561-014-0013-7. Epub 2014 Aug 20.

Supplemental Content

Loading ...
Support Center